Longevity Health Holdings, Inc. (XAGE)

NASDAQ: XAGE · Real-Time Price · USD

0.1230

-0.0320 (-20.65%)

At close: Mar 28, 2025, 4:00 PM

0.1200

-0.0030 (-2.44%)

After-hours: Mar 28, 2025, 7:09 PM EDT

Longevity Health Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	4.06	2.62	3.22	0.86
Research & Development	0.21	2.5	2.2	0.98
Operating Expenses	4.35	5.22	5.51	1.94
Operating Income	-4.32	-5.22	-5.51	-1.94
Interest Expense	-0.06	-0.89	-3.75	-2.5
Other Non Operating Income (Expenses)	-5.31	-9.37	1.27	-2.48
EBT Excluding Unusual Items	-9.7	-15.48	-7.99	-6.92
Merger & Restructuring Charges	-	-0.73	-	-
Other Unusual Items	-0.04	-	-1.06	0.44
Pretax Income	-9.75	-16.21	-9.05	-6.48
Earnings From Continuing Operations	-9.75	-16.21	-9.05	-6.48
Earnings From Discontinued Operations	3.45	0.76	-	-
Net Income	-6.3	-15.45	-9.05	-6.48
Preferred Dividends & Other Adjustments	-	0.68	0.56	0.31
Net Income to Common	-6.3	-16.12	-9.61	-6.79
Shares Outstanding (Basic)	22	11	2	23
Shares Outstanding (Diluted)	22	11	2	23
Shares Change (YoY)	287.99%	527.34%	-92.41%	-
EPS (Basic)	-0.29	-1.46	-5.47	-0.29
EPS (Diluted)	-0.29	-1.46	-5.47	-0.29
Free Cash Flow	-7.03	-8.38	-3.44	-1.18
Free Cash Flow Per Share	-0.32	-0.76	-1.96	-0.05
EBITDA	-4.24	-5.12	-5.41	-1.85
D&A For EBITDA	0.09	0.1	0.09	0.09
EBIT	-4.32	-5.22	-5.51	-1.94

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.